🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor world...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-04-01
Trial ID
NCT07531979
Treatments Being Tested
Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Status
Recruiting
Location
the First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-01
Trial ID
NCT06896422
Treatments Being Tested
The goal of this clinical trial is to learn if diphenhydramine can improve ...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2024-12
Trial ID
NCT06704620
Treatments Being Tested
Cholangiocarcinoma (CCA) is a heterogeneous group of cancers arising from t...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2023-09-01
Trial ID
NCT05823311
Treatments Being Tested
This is a multicenter, open-label, prospective, single-arm, phase II study ...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-10-25
Trial ID
NCT07296705
Treatments Being Tested
This is a prospective, open, multicenter, Phase II single-arm clinical stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-31
Trial ID
NCT06908733
The purpose of this study is to evaluate the safety, tolerability and preli...
Status
Recruiting
Location
Jilin Cancer Hospital
Start Date
2026-08-13
Trial ID
NCT07700667
Treatments Being Tested
This study was designed to compare the efficacy and safety of tislelizumab ...
Status
Completed
Location
University of California Davis Health System
Start Date
2018-12-13
Trial ID
NCT03777657
Treatments Being Tested
To explore the efficacy and safety of Tislelizumab combined with chemothera...
Status
Recruiting
Location
Anhui Cancer Hospital
Start Date
2025-02-25
Trial ID
NCT06838208
Treatments Being Tested